nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—malignant glioma—brain cancer	0.355	1	CtDrD
Temozolomide—Alkylating Activity—Lomustine—brain cancer	0.216	0.371	CiPCiCtD
Temozolomide—Alkylating Activity—Procarbazine—brain cancer	0.216	0.371	CiPCiCtD
Temozolomide—Alkylating Activity—Carmustine—brain cancer	0.149	0.257	CiPCiCtD
Temozolomide—CYP3A4—Lomustine—brain cancer	0.0173	0.805	CbGbCtD
Temozolomide—CYP3A4—Etoposide—brain cancer	0.00417	0.195	CbGbCtD
Temozolomide—Photosensitivity reaction—Procarbazine—brain cancer	0.000136	0.00318	CcSEcCtD
Temozolomide—Neoplasm—Carmustine—brain cancer	0.000135	0.00314	CcSEcCtD
Temozolomide—Pneumonia—Procarbazine—brain cancer	0.000134	0.00312	CcSEcCtD
Temozolomide—Infection—Lomustine—brain cancer	0.000133	0.0031	CcSEcCtD
Temozolomide—Thrombocytopenia—Lomustine—brain cancer	0.000131	0.00305	CcSEcCtD
Temozolomide—Pain—Carboplatin—brain cancer	0.000131	0.00305	CcSEcCtD
Temozolomide—Neuropathy peripheral—Procarbazine—brain cancer	0.00013	0.00304	CcSEcCtD
Temozolomide—Abnormal vision—Carmustine—brain cancer	0.00013	0.00303	CcSEcCtD
Temozolomide—Stomatitis—Procarbazine—brain cancer	0.00013	0.00303	CcSEcCtD
Temozolomide—Mental disability—Carmustine—brain cancer	0.000129	0.00301	CcSEcCtD
Temozolomide—Face oedema—Hydroxyurea—brain cancer	0.000129	0.00301	CcSEcCtD
Temozolomide—Anorexia—Lomustine—brain cancer	0.000127	0.00297	CcSEcCtD
Temozolomide—Thrombophlebitis—Carmustine—brain cancer	0.000125	0.00291	CcSEcCtD
Temozolomide—Body temperature increased—Carboplatin—brain cancer	0.000121	0.00282	CcSEcCtD
Temozolomide—Breast disorder—Hydroxyurea—brain cancer	0.000121	0.00282	CcSEcCtD
Temozolomide—Haemoglobin—Procarbazine—brain cancer	0.00012	0.0028	CcSEcCtD
Temozolomide—Eye pain—Carmustine—brain cancer	0.00012	0.00279	CcSEcCtD
Temozolomide—Haemorrhage—Procarbazine—brain cancer	0.000119	0.00279	CcSEcCtD
Temozolomide—Hallucination—Procarbazine—brain cancer	0.000119	0.00277	CcSEcCtD
Temozolomide—Decreased appetite—Lomustine—brain cancer	0.000116	0.00271	CcSEcCtD
Temozolomide—Phosphatase alkaline increased—Etoposide—brain cancer	0.000115	0.00269	CcSEcCtD
Temozolomide—Amnesia—Carmustine—brain cancer	0.000115	0.00268	CcSEcCtD
Temozolomide—Flushing—Procarbazine—brain cancer	0.000111	0.00259	CcSEcCtD
Temozolomide—Candida infection—Etoposide—brain cancer	0.00011	0.00256	CcSEcCtD
Temozolomide—Skin exfoliation—Etoposide—brain cancer	0.00011	0.00256	CcSEcCtD
Temozolomide—Pancytopenia—Hydroxyurea—brain cancer	0.00011	0.00256	CcSEcCtD
Temozolomide—Neuropathy—Etoposide—brain cancer	0.000108	0.00252	CcSEcCtD
Temozolomide—Diplopia—Carmustine—brain cancer	0.000108	0.00252	CcSEcCtD
Temozolomide—Dysuria—Hydroxyurea—brain cancer	0.000108	0.00252	CcSEcCtD
Temozolomide—Neutropenia—Hydroxyurea—brain cancer	0.000108	0.00252	CcSEcCtD
Temozolomide—Chills—Procarbazine—brain cancer	0.000107	0.0025	CcSEcCtD
Temozolomide—Body temperature increased—Lomustine—brain cancer	0.000106	0.00247	CcSEcCtD
Temozolomide—Alopecia—Procarbazine—brain cancer	0.000106	0.00246	CcSEcCtD
Temozolomide—Weight increased—Hydroxyurea—brain cancer	0.000105	0.00245	CcSEcCtD
Temozolomide—Face oedema—Carmustine—brain cancer	0.000104	0.00243	CcSEcCtD
Temozolomide—Infestation NOS—Hydroxyurea—brain cancer	0.000103	0.0024	CcSEcCtD
Temozolomide—Infestation—Hydroxyurea—brain cancer	0.000103	0.0024	CcSEcCtD
Temozolomide—Ataxia—Carmustine—brain cancer	0.000102	0.00237	CcSEcCtD
Temozolomide—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000101	0.00236	CcSEcCtD
Temozolomide—Stomatitis—Hydroxyurea—brain cancer	0.0001	0.00234	CcSEcCtD
Temozolomide—Hypokalaemia—Carmustine—brain cancer	9.83e-05	0.00229	CcSEcCtD
Temozolomide—Tremor—Procarbazine—brain cancer	9.74e-05	0.00227	CcSEcCtD
Temozolomide—Hepatobiliary disease—Hydroxyurea—brain cancer	9.74e-05	0.00227	CcSEcCtD
Temozolomide—Anaemia—Procarbazine—brain cancer	9.61e-05	0.00224	CcSEcCtD
Temozolomide—Blood alkaline phosphatase increased—Etoposide—brain cancer	9.6e-05	0.00224	CcSEcCtD
Temozolomide—Muscular weakness—Carmustine—brain cancer	9.53e-05	0.00222	CcSEcCtD
Temozolomide—Dysphagia—Carmustine—brain cancer	9.33e-05	0.00218	CcSEcCtD
Temozolomide—Leukopenia—Procarbazine—brain cancer	9.31e-05	0.00217	CcSEcCtD
Temozolomide—Haemoglobin—Hydroxyurea—brain cancer	9.29e-05	0.00217	CcSEcCtD
Temozolomide—Haemorrhage—Hydroxyurea—brain cancer	9.24e-05	0.00216	CcSEcCtD
Temozolomide—Hallucination—Hydroxyurea—brain cancer	9.2e-05	0.00215	CcSEcCtD
Temozolomide—Cough—Procarbazine—brain cancer	9.07e-05	0.00212	CcSEcCtD
Temozolomide—Convulsion—Procarbazine—brain cancer	9.01e-05	0.0021	CcSEcCtD
Temozolomide—Hypertension—Procarbazine—brain cancer	8.98e-05	0.00209	CcSEcCtD
Temozolomide—Pancytopenia—Carmustine—brain cancer	8.86e-05	0.00207	CcSEcCtD
Temozolomide—Myalgia—Procarbazine—brain cancer	8.85e-05	0.00207	CcSEcCtD
Temozolomide—Arthralgia—Procarbazine—brain cancer	8.85e-05	0.00207	CcSEcCtD
Temozolomide—Anxiety—Procarbazine—brain cancer	8.82e-05	0.00206	CcSEcCtD
Temozolomide—Neutropenia—Carmustine—brain cancer	8.73e-05	0.00204	CcSEcCtD
Temozolomide—Dry mouth—Procarbazine—brain cancer	8.66e-05	0.00202	CcSEcCtD
Temozolomide—Confusional state—Procarbazine—brain cancer	8.56e-05	0.002	CcSEcCtD
Temozolomide—Vomiting—Lomustine—brain cancer	8.5e-05	0.00198	CcSEcCtD
Temozolomide—Oedema—Procarbazine—brain cancer	8.48e-05	0.00198	CcSEcCtD
Temozolomide—Infection—Procarbazine—brain cancer	8.43e-05	0.00197	CcSEcCtD
Temozolomide—Hyperglycaemia—Carmustine—brain cancer	8.42e-05	0.00197	CcSEcCtD
Temozolomide—Angiopathy—Hydroxyurea—brain cancer	8.39e-05	0.00196	CcSEcCtD
Temozolomide—Pneumonia—Carmustine—brain cancer	8.37e-05	0.00195	CcSEcCtD
Temozolomide—Thrombocytopenia—Procarbazine—brain cancer	8.31e-05	0.00194	CcSEcCtD
Temozolomide—Depression—Carmustine—brain cancer	8.3e-05	0.00194	CcSEcCtD
Temozolomide—Chills—Hydroxyurea—brain cancer	8.29e-05	0.00194	CcSEcCtD
Temozolomide—Hyperhidrosis—Procarbazine—brain cancer	8.2e-05	0.00191	CcSEcCtD
Temozolomide—Alopecia—Hydroxyurea—brain cancer	8.17e-05	0.00191	CcSEcCtD
Temozolomide—Neuropathy peripheral—Carmustine—brain cancer	8.16e-05	0.0019	CcSEcCtD
Temozolomide—Stomatitis—Carmustine—brain cancer	8.11e-05	0.00189	CcSEcCtD
Temozolomide—Urinary tract infection—Carmustine—brain cancer	8.09e-05	0.00189	CcSEcCtD
Temozolomide—Anorexia—Procarbazine—brain cancer	8.09e-05	0.00189	CcSEcCtD
Temozolomide—Erythema—Hydroxyurea—brain cancer	8.05e-05	0.00188	CcSEcCtD
Temozolomide—Nausea—Lomustine—brain cancer	7.94e-05	0.00185	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Procarbazine—brain cancer	7.73e-05	0.0018	CcSEcCtD
Temozolomide—Insomnia—Procarbazine—brain cancer	7.67e-05	0.00179	CcSEcCtD
Temozolomide—Paraesthesia—Procarbazine—brain cancer	7.62e-05	0.00178	CcSEcCtD
Temozolomide—Somnolence—Procarbazine—brain cancer	7.54e-05	0.00176	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Etoposide—brain cancer	7.52e-05	0.00176	CcSEcCtD
Temozolomide—Haemoglobin—Carmustine—brain cancer	7.51e-05	0.00175	CcSEcCtD
Temozolomide—Haemorrhage—Carmustine—brain cancer	7.47e-05	0.00174	CcSEcCtD
Temozolomide—Ill-defined disorder—Hydroxyurea—brain cancer	7.47e-05	0.00174	CcSEcCtD
Temozolomide—Anaemia—Hydroxyurea—brain cancer	7.44e-05	0.00174	CcSEcCtD
Temozolomide—Hypoaesthesia—Carmustine—brain cancer	7.43e-05	0.00174	CcSEcCtD
Temozolomide—Hallucination—Carmustine—brain cancer	7.43e-05	0.00174	CcSEcCtD
Temozolomide—Decreased appetite—Procarbazine—brain cancer	7.38e-05	0.00172	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Etoposide—brain cancer	7.37e-05	0.00172	CcSEcCtD
Temozolomide—Oedema peripheral—Carmustine—brain cancer	7.36e-05	0.00172	CcSEcCtD
Temozolomide—Connective tissue disorder—Carmustine—brain cancer	7.34e-05	0.00171	CcSEcCtD
Temozolomide—Fatigue—Procarbazine—brain cancer	7.31e-05	0.00171	CcSEcCtD
Temozolomide—Malaise—Hydroxyurea—brain cancer	7.26e-05	0.00169	CcSEcCtD
Temozolomide—Pain—Procarbazine—brain cancer	7.26e-05	0.00169	CcSEcCtD
Temozolomide—Constipation—Procarbazine—brain cancer	7.26e-05	0.00169	CcSEcCtD
Temozolomide—Dysphagia—Etoposide—brain cancer	7.22e-05	0.00168	CcSEcCtD
Temozolomide—Leukopenia—Hydroxyurea—brain cancer	7.2e-05	0.00168	CcSEcCtD
Temozolomide—Visual impairment—Carmustine—brain cancer	7.2e-05	0.00168	CcSEcCtD
Temozolomide—Sweating increased—Etoposide—brain cancer	7.03e-05	0.00164	CcSEcCtD
Temozolomide—Feeling abnormal—Procarbazine—brain cancer	6.99e-05	0.00163	CcSEcCtD
Temozolomide—Eye disorder—Carmustine—brain cancer	6.98e-05	0.00163	CcSEcCtD
Temozolomide—Convulsion—Hydroxyurea—brain cancer	6.97e-05	0.00163	CcSEcCtD
Temozolomide—Gastrointestinal pain—Procarbazine—brain cancer	6.94e-05	0.00162	CcSEcCtD
Temozolomide—Flushing—Carmustine—brain cancer	6.93e-05	0.00162	CcSEcCtD
Temozolomide—Pancytopenia—Etoposide—brain cancer	6.86e-05	0.0016	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	6.8e-05	0.00159	CcSEcCtD
Temozolomide—Discomfort—Hydroxyurea—brain cancer	6.77e-05	0.00158	CcSEcCtD
Temozolomide—Neutropenia—Etoposide—brain cancer	6.75e-05	0.00158	CcSEcCtD
Temozolomide—Urticaria—Procarbazine—brain cancer	6.74e-05	0.00157	CcSEcCtD
Temozolomide—Abdominal pain—Procarbazine—brain cancer	6.71e-05	0.00157	CcSEcCtD
Temozolomide—Body temperature increased—Procarbazine—brain cancer	6.71e-05	0.00157	CcSEcCtD
Temozolomide—Alopecia—Carmustine—brain cancer	6.6e-05	0.00154	CcSEcCtD
Temozolomide—Oedema—Hydroxyurea—brain cancer	6.57e-05	0.00153	CcSEcCtD
Temozolomide—Mental disorder—Carmustine—brain cancer	6.55e-05	0.00153	CcSEcCtD
Temozolomide—Infection—Hydroxyurea—brain cancer	6.52e-05	0.00152	CcSEcCtD
Temozolomide—Erythema—Carmustine—brain cancer	6.5e-05	0.00152	CcSEcCtD
Temozolomide—Malnutrition—Carmustine—brain cancer	6.5e-05	0.00152	CcSEcCtD
Temozolomide—Pneumonia—Etoposide—brain cancer	6.47e-05	0.00151	CcSEcCtD
Temozolomide—Nervous system disorder—Hydroxyurea—brain cancer	6.44e-05	0.0015	CcSEcCtD
Temozolomide—Infestation NOS—Etoposide—brain cancer	6.44e-05	0.0015	CcSEcCtD
Temozolomide—Infestation—Etoposide—brain cancer	6.44e-05	0.0015	CcSEcCtD
Temozolomide—Thrombocytopenia—Hydroxyurea—brain cancer	6.43e-05	0.0015	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Etoposide—brain cancer	6.38e-05	0.00149	CcSEcCtD
Temozolomide—Skin disorder—Hydroxyurea—brain cancer	6.38e-05	0.00149	CcSEcCtD
Temozolomide—Neuropathy peripheral—Etoposide—brain cancer	6.31e-05	0.00147	CcSEcCtD
Temozolomide—Back pain—Carmustine—brain cancer	6.29e-05	0.00147	CcSEcCtD
Temozolomide—Stomatitis—Etoposide—brain cancer	6.27e-05	0.00146	CcSEcCtD
Temozolomide—Anorexia—Hydroxyurea—brain cancer	6.26e-05	0.00146	CcSEcCtD
Temozolomide—Hypersensitivity—Procarbazine—brain cancer	6.25e-05	0.00146	CcSEcCtD
Temozolomide—Vision blurred—Carmustine—brain cancer	6.13e-05	0.00143	CcSEcCtD
Temozolomide—Tremor—Carmustine—brain cancer	6.09e-05	0.00142	CcSEcCtD
Temozolomide—Asthenia—Procarbazine—brain cancer	6.09e-05	0.00142	CcSEcCtD
Temozolomide—Hepatobiliary disease—Etoposide—brain cancer	6.09e-05	0.00142	CcSEcCtD
Temozolomide—Anaemia—Carmustine—brain cancer	6.01e-05	0.0014	CcSEcCtD
Temozolomide—Pruritus—Procarbazine—brain cancer	6e-05	0.0014	CcSEcCtD
Temozolomide—Agitation—Carmustine—brain cancer	5.98e-05	0.0014	CcSEcCtD
Temozolomide—Dyspnoea—Hydroxyurea—brain cancer	5.85e-05	0.00137	CcSEcCtD
Temozolomide—Somnolence—Hydroxyurea—brain cancer	5.84e-05	0.00136	CcSEcCtD
Temozolomide—Leukopenia—Carmustine—brain cancer	5.82e-05	0.00136	CcSEcCtD
Temozolomide—Diarrhoea—Procarbazine—brain cancer	5.81e-05	0.00135	CcSEcCtD
Temozolomide—Dyspepsia—Hydroxyurea—brain cancer	5.78e-05	0.00135	CcSEcCtD
Temozolomide—Hypoaesthesia—Etoposide—brain cancer	5.75e-05	0.00134	CcSEcCtD
Temozolomide—Decreased appetite—Hydroxyurea—brain cancer	5.71e-05	0.00133	CcSEcCtD
Temozolomide—Urinary tract disorder—Etoposide—brain cancer	5.71e-05	0.00133	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Hydroxyurea—brain cancer	5.67e-05	0.00132	CcSEcCtD
Temozolomide—Urethral disorder—Etoposide—brain cancer	5.66e-05	0.00132	CcSEcCtD
Temozolomide—Fatigue—Hydroxyurea—brain cancer	5.66e-05	0.00132	CcSEcCtD
Temozolomide—Convulsion—Carmustine—brain cancer	5.64e-05	0.00132	CcSEcCtD
Temozolomide—Hypertension—Carmustine—brain cancer	5.62e-05	0.00131	CcSEcCtD
Temozolomide—Constipation—Hydroxyurea—brain cancer	5.62e-05	0.00131	CcSEcCtD
Temozolomide—Pain—Hydroxyurea—brain cancer	5.62e-05	0.00131	CcSEcCtD
Temozolomide—Dizziness—Procarbazine—brain cancer	5.61e-05	0.00131	CcSEcCtD
Temozolomide—Myalgia—Carmustine—brain cancer	5.54e-05	0.00129	CcSEcCtD
Temozolomide—Anxiety—Carmustine—brain cancer	5.52e-05	0.00129	CcSEcCtD
Temozolomide—Erythema multiforme—Etoposide—brain cancer	5.46e-05	0.00128	CcSEcCtD
Temozolomide—Feeling abnormal—Hydroxyurea—brain cancer	5.41e-05	0.00126	CcSEcCtD
Temozolomide—Eye disorder—Etoposide—brain cancer	5.4e-05	0.00126	CcSEcCtD
Temozolomide—Vomiting—Procarbazine—brain cancer	5.39e-05	0.00126	CcSEcCtD
Temozolomide—Flushing—Etoposide—brain cancer	5.36e-05	0.00125	CcSEcCtD
Temozolomide—Cardiac disorder—Etoposide—brain cancer	5.36e-05	0.00125	CcSEcCtD
Temozolomide—Confusional state—Carmustine—brain cancer	5.35e-05	0.00125	CcSEcCtD
Temozolomide—Rash—Procarbazine—brain cancer	5.35e-05	0.00125	CcSEcCtD
Temozolomide—Dermatitis—Procarbazine—brain cancer	5.34e-05	0.00125	CcSEcCtD
Temozolomide—Headache—Procarbazine—brain cancer	5.32e-05	0.00124	CcSEcCtD
Temozolomide—Oedema—Carmustine—brain cancer	5.31e-05	0.00124	CcSEcCtD
Temozolomide—Infection—Carmustine—brain cancer	5.27e-05	0.00123	CcSEcCtD
Temozolomide—Angiopathy—Etoposide—brain cancer	5.24e-05	0.00122	CcSEcCtD
Temozolomide—Immune system disorder—Etoposide—brain cancer	5.22e-05	0.00122	CcSEcCtD
Temozolomide—Mediastinal disorder—Etoposide—brain cancer	5.21e-05	0.00122	CcSEcCtD
Temozolomide—Thrombocytopenia—Carmustine—brain cancer	5.2e-05	0.00121	CcSEcCtD
Temozolomide—Body temperature increased—Hydroxyurea—brain cancer	5.19e-05	0.00121	CcSEcCtD
Temozolomide—Chills—Etoposide—brain cancer	5.18e-05	0.00121	CcSEcCtD
Temozolomide—Alopecia—Etoposide—brain cancer	5.11e-05	0.00119	CcSEcCtD
Temozolomide—Anorexia—Carmustine—brain cancer	5.06e-05	0.00118	CcSEcCtD
Temozolomide—Nausea—Procarbazine—brain cancer	5.04e-05	0.00118	CcSEcCtD
Temozolomide—Dysgeusia—Etoposide—brain cancer	4.93e-05	0.00115	CcSEcCtD
Temozolomide—Back pain—Etoposide—brain cancer	4.87e-05	0.00114	CcSEcCtD
Temozolomide—Hypersensitivity—Hydroxyurea—brain cancer	4.84e-05	0.00113	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Carmustine—brain cancer	4.84e-05	0.00113	CcSEcCtD
Temozolomide—Insomnia—Carmustine—brain cancer	4.8e-05	0.00112	CcSEcCtD
Temozolomide—Paraesthesia—Carmustine—brain cancer	4.77e-05	0.00111	CcSEcCtD
Temozolomide—Dyspnoea—Carmustine—brain cancer	4.73e-05	0.0011	CcSEcCtD
Temozolomide—Somnolence—Carmustine—brain cancer	4.72e-05	0.0011	CcSEcCtD
Temozolomide—Asthenia—Hydroxyurea—brain cancer	4.71e-05	0.0011	CcSEcCtD
Temozolomide—Ill-defined disorder—Etoposide—brain cancer	4.67e-05	0.00109	CcSEcCtD
Temozolomide—Anaemia—Etoposide—brain cancer	4.65e-05	0.00108	CcSEcCtD
Temozolomide—Decreased appetite—Carmustine—brain cancer	4.61e-05	0.00108	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Carmustine—brain cancer	4.58e-05	0.00107	CcSEcCtD
Temozolomide—Pain—Carmustine—brain cancer	4.54e-05	0.00106	CcSEcCtD
Temozolomide—Constipation—Carmustine—brain cancer	4.54e-05	0.00106	CcSEcCtD
Temozolomide—Malaise—Etoposide—brain cancer	4.54e-05	0.00106	CcSEcCtD
Temozolomide—Vertigo—Etoposide—brain cancer	4.52e-05	0.00105	CcSEcCtD
Temozolomide—Leukopenia—Etoposide—brain cancer	4.5e-05	0.00105	CcSEcCtD
Temozolomide—Diarrhoea—Hydroxyurea—brain cancer	4.49e-05	0.00105	CcSEcCtD
Temozolomide—Cough—Etoposide—brain cancer	4.39e-05	0.00102	CcSEcCtD
Temozolomide—Feeling abnormal—Carmustine—brain cancer	4.37e-05	0.00102	CcSEcCtD
Temozolomide—Convulsion—Etoposide—brain cancer	4.36e-05	0.00102	CcSEcCtD
Temozolomide—Hypertension—Etoposide—brain cancer	4.34e-05	0.00101	CcSEcCtD
Temozolomide—Dizziness—Hydroxyurea—brain cancer	4.34e-05	0.00101	CcSEcCtD
Temozolomide—Gastrointestinal pain—Carmustine—brain cancer	4.34e-05	0.00101	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	4.25e-05	0.000993	CcSEcCtD
Temozolomide—Discomfort—Etoposide—brain cancer	4.23e-05	0.000987	CcSEcCtD
Temozolomide—Abdominal pain—Carmustine—brain cancer	4.2e-05	0.000979	CcSEcCtD
Temozolomide—Body temperature increased—Carmustine—brain cancer	4.2e-05	0.000979	CcSEcCtD
Temozolomide—Vomiting—Hydroxyurea—brain cancer	4.18e-05	0.000974	CcSEcCtD
Temozolomide—Rash—Hydroxyurea—brain cancer	4.14e-05	0.000966	CcSEcCtD
Temozolomide—Confusional state—Etoposide—brain cancer	4.14e-05	0.000966	CcSEcCtD
Temozolomide—Dermatitis—Hydroxyurea—brain cancer	4.14e-05	0.000965	CcSEcCtD
Temozolomide—Headache—Hydroxyurea—brain cancer	4.11e-05	0.00096	CcSEcCtD
Temozolomide—Anaphylactic shock—Etoposide—brain cancer	4.1e-05	0.000958	CcSEcCtD
Temozolomide—Infection—Etoposide—brain cancer	4.08e-05	0.000952	CcSEcCtD
Temozolomide—Thrombocytopenia—Etoposide—brain cancer	4.02e-05	0.000938	CcSEcCtD
Temozolomide—Skin disorder—Etoposide—brain cancer	3.99e-05	0.000931	CcSEcCtD
Temozolomide—Hyperhidrosis—Etoposide—brain cancer	3.97e-05	0.000926	CcSEcCtD
Temozolomide—Anorexia—Etoposide—brain cancer	3.91e-05	0.000913	CcSEcCtD
Temozolomide—Hypersensitivity—Carmustine—brain cancer	3.91e-05	0.000913	CcSEcCtD
Temozolomide—Nausea—Hydroxyurea—brain cancer	3.9e-05	0.00091	CcSEcCtD
Temozolomide—Asthenia—Carmustine—brain cancer	3.81e-05	0.000889	CcSEcCtD
Temozolomide—Paraesthesia—Etoposide—brain cancer	3.69e-05	0.00086	CcSEcCtD
Temozolomide—Dyspnoea—Etoposide—brain cancer	3.66e-05	0.000854	CcSEcCtD
Temozolomide—Somnolence—Etoposide—brain cancer	3.65e-05	0.000852	CcSEcCtD
Temozolomide—Diarrhoea—Carmustine—brain cancer	3.63e-05	0.000848	CcSEcCtD
Temozolomide—Decreased appetite—Etoposide—brain cancer	3.57e-05	0.000833	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Etoposide—brain cancer	3.54e-05	0.000827	CcSEcCtD
Temozolomide—Fatigue—Etoposide—brain cancer	3.54e-05	0.000826	CcSEcCtD
Temozolomide—Dizziness—Carmustine—brain cancer	3.51e-05	0.000819	CcSEcCtD
Temozolomide—Constipation—Etoposide—brain cancer	3.51e-05	0.000819	CcSEcCtD
Temozolomide—Pain—Etoposide—brain cancer	3.51e-05	0.000819	CcSEcCtD
Temozolomide—Feeling abnormal—Etoposide—brain cancer	3.38e-05	0.000789	CcSEcCtD
Temozolomide—Vomiting—Carmustine—brain cancer	3.38e-05	0.000788	CcSEcCtD
Temozolomide—Gastrointestinal pain—Etoposide—brain cancer	3.36e-05	0.000783	CcSEcCtD
Temozolomide—Rash—Carmustine—brain cancer	3.35e-05	0.000781	CcSEcCtD
Temozolomide—Dermatitis—Carmustine—brain cancer	3.34e-05	0.00078	CcSEcCtD
Temozolomide—Headache—Carmustine—brain cancer	3.33e-05	0.000776	CcSEcCtD
Temozolomide—Urticaria—Etoposide—brain cancer	3.26e-05	0.000761	CcSEcCtD
Temozolomide—Abdominal pain—Etoposide—brain cancer	3.24e-05	0.000757	CcSEcCtD
Temozolomide—Body temperature increased—Etoposide—brain cancer	3.24e-05	0.000757	CcSEcCtD
Temozolomide—Nausea—Carmustine—brain cancer	3.15e-05	0.000736	CcSEcCtD
Temozolomide—Hypersensitivity—Etoposide—brain cancer	3.02e-05	0.000706	CcSEcCtD
Temozolomide—Asthenia—Etoposide—brain cancer	2.95e-05	0.000687	CcSEcCtD
Temozolomide—Pruritus—Etoposide—brain cancer	2.9e-05	0.000678	CcSEcCtD
Temozolomide—Diarrhoea—Etoposide—brain cancer	2.81e-05	0.000656	CcSEcCtD
Temozolomide—Dizziness—Etoposide—brain cancer	2.71e-05	0.000634	CcSEcCtD
Temozolomide—Vomiting—Etoposide—brain cancer	2.61e-05	0.000609	CcSEcCtD
Temozolomide—Rash—Etoposide—brain cancer	2.59e-05	0.000604	CcSEcCtD
Temozolomide—Dermatitis—Etoposide—brain cancer	2.59e-05	0.000604	CcSEcCtD
Temozolomide—Headache—Etoposide—brain cancer	2.57e-05	0.0006	CcSEcCtD
Temozolomide—Nausea—Etoposide—brain cancer	2.44e-05	0.000569	CcSEcCtD
